Last reviewed · How we verify

NCT05976399

Manual Lymph Drainage in Individuals With Migraine

Completed NA Last updated 8 August 2023
What this trial tests

NA trial testing Connective Tissue Massage in Manual Lymphatic Drainage in 40 participants. Completed in 8 February 2021.

Timeline
6 June 2019
Primary endpoint
15 October 2020
8 February 2021

Quick facts

Lead sponsorIzmir Democracy University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date6 June 2019
Primary completion15 October 2020
Estimated completion8 February 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Izmir Democracy University

Who can join

Adults 18 to 65, any sex, with Manual Lymphatic Drainage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the literature, research into the examination of the effect of MLD on migraine is quite limited. Our study aimed to examine the effectiveness of manual lymph drainage and connective tissue massage treatments on neck pain and disability, sleep quality, pain threshold and severity, depression and quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of the efficacy of connective tissue massage and manual lymphatic drainage in patients with migraine: a randomized controlled trial.
    Yıldırım Bulut B, Çinar Özdemir Ö. · · 2025 · PMID 41070573 · DOI 10.22514/jofph.2025.054

Verify or expand the search:

Other trials of Connective Tissue Massage

Trials testing the same drug.

Other Izmir Democracy University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05976399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing